Intracranial Hemorrhage Mortality in Atrial Fibrillation Patients Treated With Dabigatran or Warfarin

被引:56
作者
Alonso, Alvaro [1 ]
Bengtson, Lindsay G. S. [1 ]
MacLehose, Richard F. [1 ]
Lutsey, Pamela L. [1 ]
Chen, Lin Y. [2 ]
Lakshminarayan, Kamakshi [1 ,3 ]
机构
[1] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55454 USA
[2] Univ Minnesota, Sch Med, Div Cardiovasc, Dept Med, Minneapolis, MN 55454 USA
[3] Univ Minnesota, Sch Med, Dept Neurol, Minneapolis, MN 55454 USA
基金
美国国家卫生研究院;
关键词
atrial fibrillation; dabigatran; intracranial hemorrhages; warfarin; VALIDATED METHODS; ANTICOAGULATION; RIVAROXABAN; STROKE;
D O I
10.1161/STROKEAHA.114.006016
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-In randomized trials, patients with atrial fibrillation (AF) receiving dabigatran, a direct oral anticoagulant, had lower risk of intracranial bleeding (ICB) than those on warfarin. However, concerns exist about potential worse outcomes in dabigatran users if bleeding occurs, given the lack of approved reversal agents. Thus, we examined in-hospital mortality in AF patients with ICB being treated with dabigatran versus warfarin in a real-world population in the United States. Methods-We analyzed healthcare utilization claims in the Truven Health Marketscan Research Databases. The study sample included patients with AF admitted to a hospital with a primary diagnosis of ICB. Information on medications, inpatient, and outpatient diagnoses was obtained from available claims. Propensity score-adjusted risk ratios and 95% confidence intervals of in-hospital mortality comparing current users of dabigatran versus warfarin were estimated using relative risk regression. Results-Among 2391 AF patients admitted with ICB (2290 on warfarin, 101 on dabigatran), 531 died during their admission. In-hospital mortality was similar in those treated with warfarin (22%) or dabigatran (20%). Compared with warfarin users, the propensity score-adjusted risk ratio (95% confidence interval) of mortality in dabigatran users was 0.93 (0.62-1.37). Associations were similar across different ICB subtypes (intracerebral hemorrhage, subarachnoid hemorrhage, and subdural hematoma). Conclusions-In this sample of AF patients with ICB on oral anticoagulants, dabigatran was not associated with higher in-hospital mortality compared with warfarin. Hence, reluctance to use dabigatran because of a lack of approved reversal agents is not supported by our results.
引用
收藏
页码:2286 / 2291
页数:6
相关论文
共 20 条
  • [1] A systematic review of validated methods for identifying cerebrovascular accident or transient ischemic attack using administrative data
    Andrade, Susan E.
    Harrold, Leslie R.
    Tjia, Jennifer
    Cutrona, Sarah L.
    Saczynski, Jane S.
    Dodd, Katherine S.
    Goldberg, Robert J.
    Gurwitz, Jerry H.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 100 - 128
  • [3] Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
    Connolly, Stuart J.
    Ezekowitz, Michael D.
    Yusuf, Salim
    Eikelboom, John
    Oldgren, Jonas
    Parekh, Amit
    Pogue, Janice
    Reilly, Paul A.
    Themeles, Ellison
    Varrone, Jeanne
    Wang, Susan
    Alings, Marco
    Xavier, Denis
    Zhu, Jun
    Diaz, Rafael
    Lewis, Basil S.
    Darius, Harald
    Diener, Hans-Christoph
    Joyner, Campbell D.
    Wallentin, Lars
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (12) : 1139 - 1151
  • [4] An automated database case definition for serious bleeding related to oral anticoagulant use
    Cunningham, Andrew
    Stein, C. Michael
    Chung, Cecilia P.
    Daugherty, James R.
    Smalley, Walter E.
    Ray, Wayne A.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 (06) : 560 - 566
  • [5] Apixaban versus Warfarin in Patients with Atrial Fibrillation
    Granger, Christopher B.
    Alexander, John H.
    McMurray, John J. V.
    Lopes, Renato D.
    Hylek, Elaine M.
    Hanna, Michael
    Al-Khalidi, Hussein R.
    Ansell, Jack
    Atar, Dan
    Avezum, Alvaro
    Cecilia Bahit, M.
    Diaz, Rafael
    Easton, J. Donald
    Ezekowitz, Justin A.
    Flaker, Greg
    Garcia, David
    Geraldes, Margarida
    Gersh, Bernard J.
    Golitsyn, Sergey
    Goto, Shinya
    Hermosillo, Antonio G.
    Hohnloser, Stefan H.
    Horowitz, John
    Mohan, Puneet
    Jansky, Petr
    Lewis, Basil S.
    Luis Lopez-Sendon, Jose
    Pais, Prem
    Parkhomenko, Alexander
    Verheugt, Freek W. A.
    Zhu, Jun
    Wallentin, Lars
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (11) : 981 - 992
  • [6] Intracranial Hemorrhage Among Patients With Atrial Fibrillation Anticoagulated With Warfarin or Rivaroxaban The Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation
    Hankey, Graeme J.
    Stevens, Susanna R.
    Piccini, Jonathan P.
    Lokhnygina, Yuliya
    Mahaffey, Kenneth W.
    Halperin, Jonathan L.
    Patel, Manesh R.
    Breithardt, Guenter
    Singer, Daniel E.
    Becker, Richard C.
    Berkowitz, Scott D.
    Paolini, John F.
    Nessel, Christopher C.
    Hacke, Werner
    Fox, Keith A. A.
    Califf, Robert M.
    [J]. STROKE, 2014, 45 (05) : 1304 - 1312
  • [7] Intracranial Hemorrhage in Atrial Fibrillation Patients During Anticoagulation With Warfarin or Dabigatran The RE-LY Trial
    Hart, Robert G.
    Diener, Hans-Christoph
    Yang, Sean
    Connolly, Stuart J.
    Wallentin, Lars
    Reilly, Paul A.
    Ezekowitz, Michael D.
    Yusuf, Salim
    [J]. STROKE, 2012, 43 (06) : 1511 - +
  • [8] January CT, 2014, CIRCULATION, V130, pE199, DOI 10.1161/CIR.0000000000000041
  • [9] A systematic review of validated methods for identifying atrial fibrillation using administrative data
    Jensen, Paul N.
    Johnson, Karin
    Floyd, James
    Heckbert, Susan R.
    Carnahan, Ryan
    Dublin, Sascha
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 141 - 147
  • [10] Anticoagulation With the Oral Direct Thrombin Inhibitor Dabigatran Does Not Enlarge Hematoma Volume in Experimental Intracerebral Hemorrhage
    Lauer, Arne
    Cianchetti, Flor A.
    Van Cott, Elizabeth M.
    Schlunk, Frieder
    Schulz, Elena
    Pfeilschifter, Waltraud
    Steinmetz, Helmuth
    Schaffer, Chris B.
    Lo, Eng H.
    Foerch, Christian
    [J]. CIRCULATION, 2011, 124 (15) : 1654 - 1662